MORGAN HILL, CA / ACCESSWIRE / October 12, 2020 / Mitre Medical Corp. (“Mitre” or “company”) is an early-stage medical device company developing the Mitral Touch®, a less invasive and safer approach to treat functional mitral valve regurgitation (FMR) and remodel the left ventricle (LV). Mitre is pleased to announce that the company will be presenting at and participating in the U.S.-Japan cross-border event, MedTech Emerging Growth Companies 2020 Virtual Roadshow. Details about the event are as follows:
|
Conference Website: |
|
|
Conference Dates: |
U.S. – October 12-14, 2020 |
|
Mitre Presentation: |
U.S. – Monday, October 12, 2020 – 8.30pmET/5.30pmPT |
|
Location: |
ZOOM |
|
Participation: |
This year the MedTech Emerging Growth Companies 2020 Virtual Roadshow will introduce over 20 emerging U.S. medical technology companies to Japanese business, financial, academic, and government experts. The event is a collaboration between the Japan Society of Northern California and US-Japan Medtech Frontiers. The virtual conference will feature thematically grouped company presentations followed by online networking sessions with presenters.
“We are excited to follow-up on the success of last year’s conference. The Mitral Touch is a great fit for the surgical expertise in Japan where beating heart surgery is performed three times more often than in the U.S. We believe that our design, coupled with this preference for beating heart surgery, may foster rapid adoption of the Mitral Touch in Japan,” stated John MacMahon, Chief Executive Officer of Mitre Medical.
About Mitre Medical Corp.
Mitre Medical Corp. is an early-stage medical device company developing the Mitral Touch®, a less invasive and safer approach to treat functional mitral valve regurgitation (FMR) and remodel the left ventricle (LV) in patients with moderate to severe MR. Mitre Medical has the potential to be the new standard of care for FMR. For more information, please visit www.mitremedical.com.
CONTACT:
Mitre Medical Corp.:
John MacMahon
Chief Executive Officer
18655 Madrone Parkway
Morgan Hill, CA 95037
Tel: +1 603.264.7751
Email: jmacmahon@mitremedical.com
Investor Contact:
Jennifer K. Zimmons, Ph.D.
Investor Relations
Zimmons International Communications
Tel: +1 917.214.3514
Email: jzimmons@zimmonsic.com
SOURCE: Mitre Medical Corp.
View source version on accesswire.com:
https://www.accesswire.com/609922/Mitre-Medical-Corp-Announces-Presentation-and-Participation-at-the-MedTech-Emerging-Growth-Companies-2020-Virtual-Roadshow
CES Official Spokesperson Highlights UOG Featured ProductsIntroducing the World's First Black Diamond Carbon & Nano…
Independent research summary reviews mechanisms, regulatory considerations, and telehealth access pathways as consumers compare growth…
Examining Akkermansia Muciniphila, Clostridium Butyricum, And The Gut Microbiome Research Behind This Probiotic GLP-1 Supplement…
Independent Analysis Examines MEDVi's Semaglutide Medication Model, FDA Compounding Framework, and Prescription Accessibility Trends Heading…
Published NAD+ research examines cellular aging pathways and mitochondrial function as prescription peptide injection access…
Recently raised $50 million with BVF Partners, Deerfield Management, founding investor Flagship Pioneering and a…